technetium-tc-99m-tetrofosmin and Fibrosarcoma

technetium-tc-99m-tetrofosmin has been researched along with Fibrosarcoma* in 2 studies

Other Studies

2 other study(ies) available for technetium-tc-99m-tetrofosmin and Fibrosarcoma

ArticleYear
FDG-PET of autoimmune-related pancreatitis: preliminary results.
    European journal of nuclear medicine, 2000, Volume: 27, Issue:12

    The purpose of this retrospective study was to elucidate the fluorine-18 fluorodeoxyglucose positron emission tomography (FDG-PET) findings in autoimmune-related pancreatitis (AIP), which is a reversible chronic pancreatitis with an autoimmune cause. The study group comprised six patients with clinically diagnosed AIP. After 370 MBq (10 mCi) of FDG had been injected intravenously, the abdomen and/or the whole body was scanned at 1 h post injection in all patients, and scanning was repeated at 2 h in four patients. PET findings were evaluated visually and/or semiquantitatively using the standardized uptake value (SUV). In four of the six patients, PET demonstrated intense uptake in the whole pancreas, which appeared swollen on computed tomography, and the accumulation increased with time in three patients. In one patient, intense focal uptake in the pancreatic head was observed, and the accumulation decreased over time. In the remaining patient, no abnormal accumulation in the pancreas was observed. Follow-up PET scanning after steroid therapy was performed in three patients, and intense FDG uptake was no longer observed. Our preliminary data show that AIP can cause intense FDG uptake in the pancreas. This fact, and the benign status of the condition, should be kept in mind when making a diagnosis with FDG-PET in patients with pancreatic disorders.

    Topics: Cell Survival; Chondrosarcoma; Fibrosarcoma; Furans; Humans; Liposarcoma; Organophosphorus Compounds; Organotechnetium Compounds; Radiopharmaceuticals; Sarcoma; Sarcoma, Synovial; Technetium Tc 99m Sestamibi; Tumor Cells, Cultured

2000
Comparative 99mTc-MIBI, 99mTc-tetrofosmin and 99mTc-furifosmin uptake in human soft tissue sarcoma cell lines.
    European journal of nuclear medicine, 2000, Volume: 27, Issue:12

    The uptake characteristics of technetium-99m hexakis-2-methoxyisobutylisonitrile (MIBI), 99mTc-tetrofosmin and 99mTc-furifosmin in human soft tissue sarcoma cell lines were investigated and compared. After 10-120 min of incubation at 37 degrees C, 32 degrees C and 22 degrees C with 99mTc-MIBI, 99mTc-tetrofosmin and 99mTc-furifosmin, the kinetics of cellular uptake of these tracers in human soft tissue sarcoma cells SW 684 (fibrosarcoma), SW 872 (liposarcoma), SW 982 (synovial sarcoma) and SW 1353 (chondrosarcoma) was assessed. The uptake of 99mTc-MIBI, 99mTc-tetrofosmin and 99mTc-furifosmin was temperature dependent. The kinetics of uptake of 99mTc-MIBI and of 99mTc-tetrofosmin was similar between fibrosarcoma and liposarcoma cells, as well as between synovial sarcoma and chondrosarcoma cells. 99mTc-furifosmin showed similar uptake kinetics in all cell lines. The uptake of 99mTc-furifosmin was, however, significantly higher in liposarcoma than in the other cells. The data indicate that the cellular uptake of 99mTc-MIBI, 99mTc-tetrofosmin and 99mTc-furifosmin is dependent on cellular metabolic activity.

    Topics: Cell Survival; Chondrosarcoma; Fibrosarcoma; Humans; Liposarcoma; Organophosphorus Compounds; Organotechnetium Compounds; Radiopharmaceuticals; Sarcoma; Sarcoma, Synovial; Technetium Tc 99m Sestamibi; Tumor Cells, Cultured

2000